Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility
- 1 July 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 113 (1) , 28-32
- https://doi.org/10.1046/j.1365-2249.1998.00625.x
Abstract
Although the importance of genetic susceptibility to IBD has been established by epidemiological studies, the genes involved remain poorly characterized. Important candidate genes include those encoding the immunoregulatory cytokines IL-2 and IL-10. The aim of this study was to assess the contribution of the IL-2 and IL-10 genes to IBD susceptibility. One hundred and ninety-eight pairs of siblings with IBD were genotyped at dinucleotide repeat polymorphisms within the IL-2 and IL-10 genes, and data analysed by the affected sib-pair method of linkage analysis and the transmission disequilibrium test (TDT). A subset of 89 affected sibling pairs was genotyped at markers flanking the IL-2 gene as part of a genome-wide search. The IL-2 polymorphism showed no linkage to IBD overall, but modest evidence for linkage to the ulcerative colitis (UC) data set (P = 0.028). A microsatellite 4 cM distal to the IL-2 gene showed a similar distortion in the ulcerative colitis subgroup (P = 0.006). The TDT showed some distortion of allelic transmission for the IL-2 polymorphism in the UC group, but this did not reach statistical significance (P = 0.09). Results for the IL-10 polymorphism were not significant. Thus the gene encoding IL-2 may contribute to UC susceptibility, but the effect is modest and must await replication in other data sets. The IL-10 gene does not appear to contribute to the risk of developing UC or Crohn's disease.Keywords
This publication has 11 references indexed in Scilit:
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12Nature Genetics, 1996
- Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel diseaseThe Lancet, 1996
- Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology, 1995
- Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire.Gut, 1993
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993
- Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.1993
- Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitisGastroenterology, 1992
- Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.Gut, 1988
- Association of the Human Lymphocyte-DR2 Antigen with Japanese Ulcerative ColitisGastroenterology, 1982